Quest Competitors

QPTFF Stock  USD 0.01  0.00  0.00%   
Quest PharmaTech competes with Sino Biopharmaceutica, Defence Therapeutics, Enlivex Therapeutics, and Achilles Therapeutics; as well as few others. The company classifies itself under Healthcare sector and is part of Biotechnology industry. Analyzing Quest PharmaTech competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Quest PharmaTech to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Quest PharmaTech Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Quest PharmaTech competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.010.010.01
Details
Intrinsic
Valuation
LowRealHigh
0.010.010.01
Details
Naive
Forecast
LowNextHigh
0.010.010.01
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Quest PharmaTech. Your research has to be compared to or analyzed against Quest PharmaTech's peers to derive any actionable benefits. When done correctly, Quest PharmaTech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Quest PharmaTech.

Quest PharmaTech Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Quest PharmaTech and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Quest and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Quest PharmaTech does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
RGBPENLV
LVCLFSBHMY
ACHLDTCFF
RGBPSBHMY
RGBPLVCLF
ENLVSBHMY
  
High negative correlations   
ACHLLVCLF
ACHLSBHMY
DTCFFSBHMY
ACHLRGBP
ACHLENLV
LVCLFDTCFF

Risk-Adjusted Indicators

There is a big difference between Quest Pink Sheet performing well and Quest PharmaTech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Quest PharmaTech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SBHMY  0.80 (0.32) 0.00  1.88  0.00 
 0.14 
 9.00 
DTCFF  4.48  1.40  0.08  5.59  4.96 
 14.75 
 85.59 
ENLV  2.99 (0.32) 0.00  1.24  0.00 
 6.54 
 26.52 
LVCLF  3.94  0.40  0.00  0.36  0.00 
 0.00 
 112.50 
MCET  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
HESG  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
MYMX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
RGBP  15.16  0.86  0.03 (0.20) 16.80 
 48.92 
 159.27 
ACHL  1.37  0.23  0.07 (2.97) 1.22 
 2.59 
 19.72 

Quest PharmaTech Competitive Analysis

The better you understand Quest PharmaTech competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Quest PharmaTech's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Quest PharmaTech's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
QPTFF SBHMY DTCFF ENLV LVCLF MYMX RGBP ACHL
 0.00 
 0.01 
Quest
 0.14 
 7.25 
Sino
 7.41 
 0.75 
Defence
 1.77 
 1.11 
Enlivex
 26.47 
 0 
Living
 0.00 
 0 
Mymetics
 11.29 
 0.06 
Regen
 0.88 
 1.12 
Achilles
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Current Valuation
Price To Book
Operating Margin
Five Year Return
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Book Value Per Share
Number Of Shares Shorted
Current Liabilities
Total Asset
Debt To Equity
Last Dividend Paid
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Quest PharmaTech Competition Performance Charts

Five steps to successful analysis of Quest PharmaTech Competition

Quest PharmaTech's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Quest PharmaTech in relation to its competition. Quest PharmaTech's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Quest PharmaTech in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Quest PharmaTech's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Quest PharmaTech, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Quest PharmaTech position

In addition to having Quest PharmaTech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Financials ETFs Thematic Idea Now

Financials ETFs
Financials ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Quest Pink Sheet

Quest PharmaTech financial ratios help investors to determine whether Quest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Quest with respect to the benefits of owning Quest PharmaTech security.